/SNCE

SNCE Stock - Science 37 Holdings, Inc.

Q: What is the analyst price target for SNCE?

Analyst price target information is not currently available for SNCE.

Q: What is SNCE's market cap?

Market capitalization information is not currently available for SNCE.

Healthcare|Medical - Healthcare Information Services|NASDAQ

$5.75+0.35%

+$0.02 (+0.35%) • Mar 11

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $6.33

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SNCE

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.56

52W High$12.96

52W Low$3.73

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2022	FY2021	FY2020	FY2019
Revenue	$70.15M	$59.60M	$23.70M	N/A
Gross Profit	$15.87M	$17.20M	$1.11M	N/A
Gross Margin	22.6%	28.9%	4.7%	N/A
Operating Income	$-105,327,000	$-63,718,000	$-31,691,000	N/A
Net Income	$-50,988,000	$-94,331,000	$-32,369,000	$-1,000
Net Margin	-72.7%	-158.3%	-136.6%	N/A
EPS	$-0.44	$-2886.59	$-2.18	$-0.00

Company Overview

Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data. Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.

Visit Website

Earnings History & Surprises

SNCE

Beat Rate

67%

Last 9 quarters

Avg Surprise

-485.2%

EPS vs Estimate

Beats / Misses

6/3

Last 12 quarters

Latest EPS

$-1.00

Q4 2023

EPS Surprise History

Q1 22

-2090.5%

$-4.60vs$-0.21

Q2 22

+13.6%

$-3.80vs$-4.40

Q3 22

+18.2%

$-3.60vs$-4.40

Q4 22

+5.9%

$-3.20vs$-3.40

Q1 23

+17.6%

$-2.80vs$-3.40

Q2 23

+21.4%

$-2.20vs$-2.80

Q3 23

-1066.7%

$-1.40vs$-0.12

Q4 23

-1328.6%

$-1.00vs$-0.07

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2024	Mar 4, 2024	$-1.23	—	—	—
Q4 2023	Nov 7, 2023	$-0.07	$-1.00	-1328.6%	✗ MISS
Q3 2023	Aug 8, 2023	$-0.12	$-1.40	-1066.7%	✗ MISS
Q2 2023	May 15, 2023	$-2.80	$-2.20	+21.4%	✓ BEAT
Q1 2023	Mar 6, 2023	$-3.40	$-2.80	+17.6%	✓ BEAT
Q4 2022	Nov 10, 2022	$-3.40	$-3.20	+5.9%	✓ BEAT
Q3 2022	Aug 11, 2022	$-4.40	$-3.60	+18.2%	✓ BEAT
Q2 2022	May 9, 2022	$-4.40	$-3.80	+13.6%	✓ BEAT
Q1 2022	Mar 22, 2022	$-0.21	$-4.60	-2090.5%	✗ MISS
Q4 2021	Nov 15, 2021	$-106.40	$-61.20	+42.5%	✓ BEAT
Q3 2021	Sep 24, 2021	—	$-0.06	—	—
Q1 2021	Feb 2, 2021	—	$-0.04	—	—
Q2 2020	Jun 29, 2020	—	$-0.00	—	—

Frequently Asked Questions about SNCE

What is SNCE's current stock price?

Science 37 Holdings, Inc. (SNCE) is currently trading at $5.75 per share. The stock has moved +0.35% today.

What is the analyst price target for SNCE?

No analyst price targets are currently available for this stock.

What sector is Science 37 Holdings, Inc. in?

Science 37 Holdings, Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NASDAQ exchange.

What is SNCE's market cap?

Science 37 Holdings, Inc. has a market capitalization of $0.03 billion, making it a small-cap company.

Does SNCE pay dividends?

No, Science 37 Holdings, Inc. does not currently pay a dividend to shareholders.